Chase Knickerbocker
Stock Analyst at Craig-Hallum
(1.93)
# 1,622
Out of 4,479 analysts
17
Total ratings
41.18%
Success rate
-7.58%
Average return
Main Sectors:
12 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DCTH Delcath Systems | Initiates: Buy | $18 | $7.91 | +127.56% | 1 | Jun 28, 2024 | |
| HROW Harrow Health | Maintains: Buy | $26 → $30 | $20.85 | +43.88% | 1 | Jun 21, 2024 | |
| FENC Fennec Pharmaceuticals | Maintains: Buy | $20 → $17 | $6.03 | +181.92% | 3 | May 15, 2024 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Buy | $18 → $14 | $6.22 | +125.08% | 2 | May 10, 2024 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $22 → $23 | $13.89 | +65.59% | 2 | May 9, 2024 | |
| ETON Eton Pharmaceuticals | Initiates: Buy | $8 | $3.28 | +143.90% | 1 | May 6, 2024 | |
| INDV Indivior | Initiates: Buy | $37 | $15.27 | +142.31% | 1 | Apr 3, 2024 | |
| ACST Acasti Pharma | Initiates: Buy | $6 | $2.85 | +110.53% | 1 | Feb 7, 2024 | |
| MDXG MiMedx Group | Initiates: Buy | $12 | $6.78 | +76.99% | 1 | Oct 27, 2023 | |
| SCPH scPharmaceuticals | Initiates: Buy | $20 | $4.21 | +375.06% | 1 | Sep 7, 2023 | |
| XTNT Xtant Medical Holdings | Maintains: Buy | $1 → $1.2 | $0.63 | +92.00% | 2 | Jul 11, 2023 | |
| PHAT Phathom Pharmaceuticals | Initiates: Buy | $21 | $10.25 | +104.88% | 1 | Mar 13, 2023 |
Delcath Systems
Jun 28, 2024
Initiates: Buy
Price Target: $18
Current: $7.91
Upside: +127.56%
Harrow Health
Jun 21, 2024
Maintains: Buy
Price Target: $26 → $30
Current: $20.85
Upside: +43.88%
Fennec Pharmaceuticals
May 15, 2024
Maintains: Buy
Price Target: $20 → $17
Current: $6.03
Upside: +181.92%
Ironwood Pharmaceuticals
May 10, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $6.22
Upside: +125.08%
Avadel Pharmaceuticals
May 9, 2024
Maintains: Buy
Price Target: $22 → $23
Current: $13.89
Upside: +65.59%
Eton Pharmaceuticals
May 6, 2024
Initiates: Buy
Price Target: $8
Current: $3.28
Upside: +143.90%
Indivior
Apr 3, 2024
Initiates: Buy
Price Target: $37
Current: $15.27
Upside: +142.31%
Acasti Pharma
Feb 7, 2024
Initiates: Buy
Price Target: $6
Current: $2.85
Upside: +110.53%
MiMedx Group
Oct 27, 2023
Initiates: Buy
Price Target: $12
Current: $6.78
Upside: +76.99%
scPharmaceuticals
Sep 7, 2023
Initiates: Buy
Price Target: $20
Current: $4.21
Upside: +375.06%
Xtant Medical Holdings
Jul 11, 2023
Maintains: Buy
Price Target: $1 → $1.2
Current: $0.63
Upside: +92.00%
Phathom Pharmaceuticals
Mar 13, 2023
Initiates: Buy
Price Target: $21
Current: $10.25
Upside: +104.88%